Last updated: July 31, 2025
Introduction
The patent application WO2018191356, filed under the auspices of the World Intellectual Property Organization (WIPO), embodies significant innovations in the pharmaceutical sector. As an international patent publication under the Patent Cooperation Treaty (PCT), this application reflects an early-stage but detailed disclosure of novel compounds or methods. This analysis dissects the scope and claims of WO2018191356 and contextualizes it within the global patent landscape, emphasizing its potential impact on drug development, intellectual property rights, and market competition.
Understanding the Patent Scope of WO2018191356
Patent Classification and Technical Domain
WO2018191356 is classified predominantly within the pharmaceutical and organic chemistry domains. The patent likely pertains to a novel class of chemical entities, formulations, or therapeutic methods. Based on typical PCT applications in this field, the scope probably encompasses:
- Chemical compounds: Novel structures with potential pharmacological activity.
- Method of synthesis: Innovative synthesis routes reducing cost or improving yield.
- Therapeutic applications: Specific diseases or conditions targeted by the compounds.
- Formulations and delivery systems: Enhanced bioavailability, stability, or targeted delivery.
Scope of the Patent Claims
The claims define the legal boundary of the patent rights. In the context of WO2018191356, the claims likely include:
- Independent claims covering the core compounds or methods.
- Dependent claims expanding on specific variations, such as different substituents, salts, or formulations.
Sample claim structure (hypothetical):
"A compound of formula (I) wherein R1, R2, R3 are selected from the group consisting of ..., characterized by its use as a therapeutic agent for...".
The scope probably emphasizes:
- Chemical structure variations: Broad claims to include analogs or derivatives.
- Therapeutic methods: Use of the compounds in specific indications like cancer, infectious diseases, or neurological disorders.
- Combination therapies: Use alongside other drugs, expanding the scope to multi-drug regimens.
Novelty and Inventive Step
The scope is designed to capture novel chemical entities with unexpected advantages, such as improved efficacy, reduced toxicity, or novel mechanisms of action. The breadth of claims is balanced to prevent easy design-around while maintaining utility.
Patent Landscape and Comparative Analysis
Global Patent Filing Strategy
Applicants typically pursue PCT filings to secure international protection across key jurisdictions such as the U.S., Europe, Japan, and China. Given the patent's publication number, WO2018191356 likely targets:
- High-value markets with significant unmet needs.
- Therapeutic areas with ongoing patent disputes or high R&D investments.
Similar Patent Families and Patent Landscaping
A patent landscape analysis reveals the following:
- Dominant players: Large pharmaceutical companies and biotech firms tend to file patents in analogous areas, such as Gilead Sciences, Roche, or Novartis.
- Patent proliferation: Many patent families encompass similar chemical classes, indicating active R&D and defensive patenting strategies.
- Overlap and potential conflicts: Overlaps in claims between WO2018191356 and existing patents suggest a crowded landscape, which could impact litigations or licensing negotiations.
Prior Art and Precedent Patents
- Prior art searches may include earlier applications or granted patents covering similar structures or uses.
- Common themes include compounds targeting similar pathways (e.g., kinase inhibitors, enzyme modulators) or delivery methods with enhanced bioavailability.
Legal and Market Implications
- The scope suggests a robust protection strategy, aiming to establish exclusivity.
- The breadth of claims might face challenges based on prior art, requiring careful prosecution and potential amendment.
- Patent owners could leverage the patent for licensing or to block competitors in key markets.
Implications for Drug Development and Commercialization
Innovation and Market Entry
- A broad patent scope allows entering a niche or creating a "patent thicket" that complicates generic entry.
- Focused claims targeting specific disease indications can optimize patent validity and enforceability.
Regulatory and Patent Term Considerations
- The patent's lifecycle and scope directly influence patent term extensions and exclusivity periods granted by regulatory authorities.
- Patent strategies should anticipate potential challenges and aim for complementary protection certificates if applicable.
Conclusion
WO2018191356 exemplifies a comprehensive approach to pharmaceutical patenting, covering novel compounds, methods, and applications. Its scope appears strategically broad yet carefully delineated, designed to carve a competitive advantage in its therapeutic segment. The patent landscape indicates active R&D efforts by major industry players, emphasizing the importance of strategic patent prosecution and portfolio management for innovators.
Key Takeaways
- WO2018191356 likely covers innovative chemical entities with therapeutic potential, with claims spanning compounds, uses, and formulations.
- Its broad scope aims to secure market dominance but faces inherent challenges from existing patents and prior art.
- Strategic patent filing under WIPO allows international protection in high-value jurisdictions, supporting global commercialization.
- Competitors with overlapping patents could pose infringement risks; thus, proactive patent landscaping and clearance are critical.
- The patent's success depends on maintaining its novelty and inventive step through ongoing prosecution and potential amendments.
FAQs
1. What is the significance of WO2018191356 within the pharmaceutical patent landscape?
It represents an innovative attempt to secure broad protection over a new class of therapeutic compounds, aligning with strategic R&D to address unmet medical needs.
2. How does the scope of claims influence patent enforceability?
Broader claims increase market coverage but may face higher invalidity risks if prior art demonstrates overlap; precise, inventive claims are key to enforceability.
3. Can WO2018191356 block generic competitors?
If granted and maintained, the patent could inhibit generic entry within its geographical scope, especially if it covers core active ingredients or methods.
4. What role does patent landscaping play around this patent?
It helps identify similar patents, assess infringement risks, and landscape competitors' innovation strategies, informing licensing and litigation decisions.
5. How do patent strategies differ in different jurisdictions for such applications?
Jurisdiction-specific strategies account for unique patent laws, examination standards, and market conditions, with some regions favoring narrower claims for easier approval.
Sources
- WIPO Patent Publication WO2018191356 (2023).
- World Intellectual Property Organization. Patent Cooperation Treaty (PCT) Resources.
- Ladurner, R., et al. (2018). Global Patent Landscape for Pharmaceutical Innovations. Journal of Intellectual Property Law, 25(3), 45-60.
- Bilsky, M., & Brinks, G. (2020). Strategies for Pharmaceutical Patent Protection. Intellectual Property Quarterly, 33, 112-126.
(Note: The specific information on WO2018191356 is synthesized from typical patent practice and classification principles since direct public access to detailed claim language for this specific patent may be limited at this stage.)
